Cargando…

P1273: INVESTIGATING THE ONCOGENIC POTENTIAL OF STAT5BN642H IN NK CELLS

Detalles Bibliográficos
Autores principales:	Klein, K., Randhawa, M., Witalisz-Siepracka, A., Trifinopoulos, J., Kudweis, P., Knab, V. M., Gotthardt, D., Sexl, V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430158/ http://dx.doi.org/10.1097/01.HS9.0000847956.95102.ab

Ejemplares similares

Triple-negative breast cancer cells rely on kinase-independent functions of CDK8 to evade NK-cell-mediated tumor surveillance
por: Knab, Vanessa Maria, et al.
Publicado: (2021)

JAK/STAT Cytokine Signaling at the Crossroad of NK Cell Development and Maturation
por: Gotthardt, Dagmar, et al.
Publicado: (2019)

STAT5B(N642H) drives transformation of NKT cells: a novel mouse model for CD56(+) T-LGL leukemia
por: Klein, Klara, et al.
Publicado: (2019)

The Multifaceted Role of STAT3 in NK-Cell Tumor Surveillance
por: Witalisz-Siepracka, Agnieszka, et al.
Publicado: (2022)

Loss of NKG2D in murine NK cells leads to increased perforin production upon long‐term stimulation with IL‐2
por: Prinz, Daniela, et al.
Publicado: (2020)

T Cell-Intrinsic CDK6 Is Dispensable for Anti-Viral and Anti-Tumor Responses In Vivo
por: Klein, Klara, et al.
Publicado: (2021)

In vivo tumor surveillance by NK cells requires TYK2 but not TYK2 kinase activity
por: Prchal-Murphy, Michaela, et al.
Publicado: (2015)

STATs in NK-Cells: The Good, the Bad, and the Ugly
por: Gotthardt, Dagmar, et al.
Publicado: (2017)

STAT1 Isoforms Differentially Regulate NK Cell Maturation and Anti-tumor Activity
por: Meissl, Katrin, et al.
Publicado: (2020)

Untwining Anti-Tumor and Immunosuppressive Effects of JAK Inhibitors—A Strategy for Hematological Malignancies?
por: Klein, Klara, et al.
Publicado: (2021)

CDK8-Novel Therapeutic Opportunities
por: Menzl, Ingeborg, et al.
Publicado: (2019)

The Ups and Downs of STAT Inhibition in Acute Myeloid Leukemia
por: Moser, Bernhard, et al.
Publicado: (2021)

Loss of JAK1 Drives Innate Immune Deficiency
por: Witalisz-Siepracka, Agnieszka, et al.
Publicado: (2019)

STAT5B(N642H) is a driver mutation for T cell neoplasia
por: Pham, Ha Thi Thanh, et al.
Publicado: (2017)

PB1805: BREAKING A PARADIGM: LOSS OF STAT3 INCREASES INVASION IN MLL-AF9-DRIVEN ACUTE MYELOID LEUKEMIA
por: Zdársky, Bernhard, et al.
Publicado: (2023)

PB1783: UNRAVELING THE TUMOR SUPPRESSIVE ROLE OF STAT3B IN ACUTE MYELOID LEUKEMIA
por: Edtmayer, Sophie, et al.
Publicado: (2023)

CDK8-Mediated STAT1-S727 Phosphorylation Restrains NK Cell Cytotoxicity and Tumor Surveillance
por: Putz, Eva Maria, et al.
Publicado: (2013)

Unexpected role of STAT1 serine727 for NK cell function
por: Putz, Eva M, et al.
Publicado: (2009)

Structural and functional consequences of the STAT5B(N642H) driver mutation
por: de Araujo, Elvin D., et al.
Publicado: (2019)

A case of hypereosinophilic syndrome with STAT5b N642H mutation
por: Ding, Feihong, et al.
Publicado: (2021)

O-GlcNAcylation of STAT5 controls tyrosine phosphorylation and oncogenic transcription in STAT5-dependent malignancies
por: Freund, P, et al.
Publicado: (2017)

STAT1 Ser727 – key regulator for NK cell-mediated cytotoxicity and tumor surveillance
por: Putz, Eva M, et al.
Publicado: (2008)

A haunted beast: Targeting STAT5B(N642H) in T-Cell Neoplasia
por: Pham, Ha Thi Thanh, et al.
Publicado: (2018)

Recurrent activating STAT5B N642H mutation in myeloid neoplasms with eosinophilia
por: Cross, Nicholas C. P., et al.
Publicado: (2018)

Opioids drive breast cancer metastasis through the δ-opioid receptor and oncogenic STAT3
por: Tripolt, Sabrina, et al.
Publicado: (2021)

Loss of STAT3 in Lymphoma Relaxes NK Cell-Mediated Tumor Surveillance
por: Putz, Eva Maria, et al.
Publicado: (2014)

A Recurrent STAT5B(N642H) Driver Mutation in Feline Alimentary T Cell Lymphoma
por: Kieslinger, Matthias, et al.
Publicado: (2021)

Recent Progress in Fabrication and Application of BN Nanostructures and BN-Based Nanohybrids
por: Shtansky, Dmitry V., et al.
Publicado: (2022)

JAK/STAT Pathway Mutations in T-ALL, Including the STAT5B N642H Mutation, are Sensitive to JAK1/JAK3 Inhibitors
por: Govaerts, Inge, et al.
Publicado: (2019)

CCNP Tshoot 642-832 quick reference
por: Stewart, Brent
Publicado: (2010)

CCNP route 642-902 quick reference
por: Donohue, Denise
Publicado: (2010)

CCNP SWITCH 642-813 quick reference
por: Donohue, Denise
Publicado: (2010)

Characterization data on the topical carrier DDC642
por: Desmet, Eline, et al.
Publicado: (2016)

PT642. The effects of caffeine on acupuncture analgesia
por: Hwang, Jeong Won, et al.
Publicado: (2016)

Decreased NK-cell tumour immunosurveillance consequent to JAK inhibition enhances metastasis in breast cancer models
por: Bottos, Alessia, et al.
Publicado: (2016)

642. Trends and cost burden of Legionella urine antigen test
por: Ordaz, Victor-mauricio, et al.
Publicado: (2020)

CCNP TSHOOT 642-832 Official Certification Guide
por: Wallace, Kevin
Publicado: (2010)

CCNP ROUTE 642-902 Official Certification Guide
por: Odom, Wendell
Publicado: (2010)

CCNP SWITCH 642-813 Official Certification Guide
por: Hucaby, David
Publicado: (2010)

CCNP Voice TVoice 642-427 Quick Reference
por: Washington, Brion
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_1rtk2bplhgq1jjm5oqjc66m0mi